secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2021-10-25T23:59:59+00:00
Accession:  0001274737-21-000106
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen refinances $27.2M term loan with Innovatus; maturity extended to Nov 2026
--------------------------------------------------------------------------------

- $27.2M term loan at 8.0% interest (2% paid in-kind) from Innovatus.
- Interest-only period extended through December 2024; maturity extended to November 19, 2026.
- Financial covenant revised to revenue-based test starting Q4 2022, with cure options via equity or sub debt.
- Effective November 1, 2021; press release issued October 25, 2021.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473721000106/0001274737-21-000106-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473721000106/exdx-20211021.htm
  HTML page:      https://secwatch.observer/filing/0001274737-21-000106

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer